Lila Sciences, an AI company dedicated to building scientific superintelligence to solve humanity’s most complex challenges, has announced the completion of a $350 million Series A round, bringing its total funding to $550 million. The funding will accelerate the development of Lila’s AI Science Factories and expand access to its autonomous scientific platform for customers tackling problems across healthcare, energy, and materials science.
The Series A financing closed in two parts, with the first co-led by Braidwell and Collective Global. Newly disclosed participants include NVentures (NVIDIA’s venture capital arm), Analog Devices (as part of Flagship Pioneering’s existing partnership), IQT, Dauntless Ventures, Catalio Capital Management, Pennant Investors, a group of investors from Peter Diamandis’ Abundance Membership, and other new stakeholders.
They join a broad coalition of existing investors from the first close, including Flagship Pioneering (where Lila originated), Altitude Life Science Ventures, Alumni Ventures, ARK Venture Fund, Common Metal, Dara Holdings, General Catalyst, March Capital, Mathers Foundation, Modi Ventures, NGS Super, the State of Michigan Retirement System, and a wholly owned subsidiary of Abu Dhabi Investment Authority (ADIA), among others.
According to the company, its investor base now represents more than $2 trillion in assets under management, spanning institutional investors, retirement systems, and impact-driven funds. Lila highlighted that this combination of AI pioneers, scientific experts, and long-term partners provides the depth and alignment needed to scale responsibly.
Lila Sciences emerged from stealth in March 2025 after two years of development within Flagship Pioneering. Its mission—to build a platform capable of “superhuman scientific performance”—focuses on accelerating discovery in life sciences, chemistry, and materials engineering.
The newly raised capital will support the company’s ambitious roadmap, including:
- Advancing superhuman scientific performance across high-value research domains in biology, chemistry, and materials.
- Expanding AI Science Factories, scaling up the number of instruments under AI control to produce more “scientific tokens” than any other organization, to uncover new scaling laws for scientific intelligence.
- Opening its platform to commercial partners, onboarding its first cohort of customers in strategic scientific fields to leverage its autonomous science platform, agent-based discovery systems, and AI-driven security protocols.
- Growing its world-class team by attracting top researchers, engineers, and innovators dedicated to reshaping how science is conducted.
Lila’s leadership emphasized that its work sits at the intersection of national resilience, industrial innovation, and scientific advancement. The company’s backers bring not only financial support but also technical collaboration and strategic alignment with U.S. and global priorities in areas like materials discovery, next-generation therapeutics, and energy infrastructure.
